As Life Sciences companies look to differentiate in an increasingly competitive market, a new technology landscape is emerging:
RBM is an evolving paradigm. And while its adoption will be gradual and the details hammered out over time, Sponsors should start working with their CRO partners now. In this new whitepaper, Medpace provides insights into how to partner to take advantage of RBM.
As payers implement new restrictions and healthcare reform presents new complexities in evaluating eligibility, manufacturers still need to ensure product success while supporting patients who need assistance. In this Executive Brief, Lash Group provides a wholistic view of current issues around co-pay programs.
This paper focuses on how customer centricity can unlock significant financial gains for pharmaceutical companies. It briefly reviews the historical promotion model, the factors in the industry that are driving the change, and then goes into depth on what it means to be customer centric and how to implement a customer-centric model.
Regulators in the US and abroad are demanding a much more proactive approach to safety and risk management. Addressing those mandates requires longer studies, larger patient pools and comprehensive risk evaluation and mitigation strategies. Effective planning must include an embedded strategy to identify and address the therapeutic, regulatory and economic concerns of diverse healthcare stakeholders, to optimize the commercial success of drug and device products.
Given the financial and health implications of non-adherence, the pursuit of greater levels of patient adherence is in the best interests of both the commercial and clinical sides of the healthcare industry. The purpose of this paper is to present some of the definitions and elements worthy of consideration, while providing some options for a brand marketer to consider as they look to increase levels of adherence.
This white paper reveals why analytics is the secret ingredient to achieving success in managed markets and explains why new legislation and other market factors have increased the risks of continuing business as usual. It then explains how you can set the stage for analytics by building the right infrastructure.
As sponsor companies struggle to replace the revenue loss threatened by generics, they are searching for more cost-effective ways to increase the number of drugs in their development pipeline. Many of them are developing clinical delivery alliances - high-level business partnerships that can modify the conventional incentive structure for conducting multi-drug development programs. Sponsors can simultaneously increase quality while decreasing costs and reducing time-to-market, if the proper structure is in place.
Outsourcing pharmacovigilance activities is a standard business practice in a rapidly expanding market segment. When outsourcing services the best relationships between sponsors and contractors are those that are well defined from the outset. This whitepaper outlines the best practices to ensure a successful and positive experience when outsourcing pharmacovigilance services.
The Netherlands offers pharmaceutical firms a favorable environment for receiving expedited study review. Clinical studies can be rapidly initiated in The Netherlands due to Dutch government regulations for clinical research. Based on years of experience operating in the Netherlands, this whitepaper will: - Outline the regulatory guidelines for studies in The Netherlands. - Highlight advantages for sponsors conducting studies in The Netherlands. - Provide details on how to appropriately navigate regulatory procedures in The Netherlands.
- 1 of 4
- Biotechnology Companies
- Contract Manufacturing
- Drug Delivery
- Drug Discovery and Pipelines
- DTC Advertising
- Healthcare Agencies
- Japanese Pharma Companies
- Life Sciences Investment
- Medical Device Companies
- New Medical Devices
- New Medicines
- Nutraceuticals and Vitamin Supplements
- Personnel and Leadership
- Pharmaceutical Companies
- Specialty Pharmaceutical Companies
- Therapeutic Categories